Eli Lilly and Company
LLY
$755.36
$3.910.52%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -5.94% | 18.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.94% | 18.30% | |||
| Cost of Revenue | -7.47% | 10.73% | |||
| Gross Profit | -5.61% | 20.08% | |||
| SG&A Expenses | 2.32% | 16.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.36% | 12.28% | |||
| Operating Income | -6.72% | 27.43% | |||
| Income Before Tax | -31.41% | 217.22% | |||
| Income Tax Expenses | 10.80% | 1.75% | |||
| Earnings from Continuing Operations | -37.43% | 354.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -37.43% | 354.48% | |||
| EBIT | -6.72% | 27.43% | |||
| EBITDA | -6.55% | 25.24% | |||
| EPS Basic | -37.12% | 353.39% | |||
| Normalized Basic EPS | -6.38% | 27.25% | |||
| EPS Diluted | -37.32% | 356.29% | |||
| Normalized Diluted EPS | -6.57% | 27.81% | |||
| Average Basic Shares Outstanding | -0.49% | 0.24% | |||
| Average Diluted Shares Outstanding | -0.28% | -0.20% | |||
| Dividend Per Share | 15.38% | 0.00% | |||
| Payout Ratio | 0.84% | -0.78% | |||